-
1دورية أكاديمية
المؤلفون: Trøseid, Marius, Arribas, José R., Assoumou, Lambert, Holten, Aleksander Rygh, Poissy, Julien, Terzic, Vida, Mazzaferri, Fulvia, Baño, Jesús Rodríguez, Eustace, Joe, Hites, Maya, Joannidis, Michael, Paiva, José-Artur, Reuter, Jean, Püntmann, Isabel, Patrick-Brown, Thale Dawn, Westerheim, Elin, Nezvalova-Henriksen, Katerina, Beniguel, Lydie, Dahl, Tuva Børresdatter, Bouscambert, Maude, Halanova, Monika, Péterfi, Zoltán, Tsiodras, Sotirios, Rezek, Michael, Briel, Matthias, Ünal, Serhat, Schlegel, Martin, Ader, Florence, Lacombe, Karine, Amdal, Cecilie Delphin, Rodrigues, Serge, Tonby, Kristian, Gaudet, Alexandre, Heggelund, Lars, Mootien, Joy, Johannessen, Asgeir, Møller, Jannicke Horjen, Pollan, Beatriz Diaz, Tveita, Anders Aune, Kildal, Anders Benjamin, Richard, Jean-Christophe, Dalgard, Olav, Simensen, Victoria Charlotte, Baldé, Aliou, de Gastines, Lucie, del Álamo, Marta, Aydin, Burç, Lund-Johansen, Fridtjof, Trabaud, Mary-Anne, Diallo, Alpha, Halvorsen, Bente, Røttingen, John-Arne, Tacconelli, Evelina, Yazdanpanah, Yazdan, Olsen, Inge Christoffer, Costagliola, Dominique, Study Group, EU-SolidAct
العلاقة: Critical Care; info:eu-repo/grantAgreement/EC/H2020/101015736/EU/European Research and Preparedness Network for Pandemics and Emerging Infectious Diseases/EU-RESPONSE/; Trøseid M, Arribas, Assoumou, Holten AR, Poissy J, Terzic, Mazzaferri, Baño, Eustace J, Hites M, Joannidis M, Paiva J, Reuter, Püntmann, Patrick-Brown J.H., Westerheim, Nezvalova-Henriksen K, Beniguel, Dahl TB, Bouscambert M, Halanova, Péterfi, Tsiodras S, Rezek, Briel M, Ünal, Schlegel, Ader F, Lacombe K, Amdal CD, Rodrigues, Tonby K, Gaudet A, Heggelund L, Mootien, Johannessen A, Møller J, Pollan, Tveita A, Kildal AB, Richard J, Dalgard O, Simensen VC, Baldé, de Gastines, del Álamo, Aydin, Lund-Johansen F, Trabaud, Diallo A, Halvorsen BE, Røttingen J, Tacconelli E, Yazdanpanah Y, Olsen IC, Costagliola D, Study Group. Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID‑19 (Bari‑SolidAct): a randomised, double‑blind, placebo‑controlled phase 3 trial. Critical Care. 2023;27(9); FRIDAID 2104449; https://hdl.handle.net/10037/28531Test
-
2
المؤلفون: Ferhat Meziani, Julien Demiselle, Nicolas Fage, Antoine Studer, Sibylle Cunat, Jean-Christophe Richard, Alain Mercat, François Beloncle, Satar Mortaza, Hamid Merdji, Laurent Brochard, Bertrand Pavlovsky, Christophe Desprez, Julie Helms, Valérie Seegers
المساهمون: Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM), MitoVasc - Physiopathologie Cardiovasculaire et Mitochondriale (MITOVASC), Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), CHU Strasbourg, Université de Strasbourg (UNISTRA), Integrated Center for Oncology [Angers] (ICO), Institut Mondor de Recherche Biomédicale (IMRB), Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), LUNAM Université [Nantes Angers Le Mans], Regenerative NanoMedicine [Strasbourg] (RNM), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM), Fédération de Médecine Translationnelle de Strasbourg (FMTS), St. Michael's Hospital, University of Toronto, RICHARD, Jean-Christophe, Physiopathologie Cardiovasculaire et Mitochondriale (MITOVASC)
المصدر: Critical Care, Vol 25, Iss 1, Pp 1-10 (2021)
Critical Care
Critical Care, 2021, 25 (1), pp.248. ⟨10.1186/s13054-021-03665-8⟩
Critical Care, BioMed Central, 2021, 25 (1), pp.248. ⟨10.1186/s13054-021-03665-8⟩مصطلحات موضوعية: Male, ARDS, Letter, Coronavirus disease 2019 (COVID-19), [SDV]Life Sciences [q-bio], medicine.medical_treatment, Respiratory mechanics, Respiratory failure, Critical Care and Intensive Care Medicine, Severity of Illness Index, Body Mass Index, Positive-Pressure Respiration, 03 medical and health sciences, Dead space, 0302 clinical medicine, Mechanical ventilation, Medicine, Humans, 030212 general & internal medicine, Respiratory system, Propensity Score, Acute Respiratory Distress Syndrome, Aged, Respiratory Distress Syndrome, Pulmonary Gas Exchange, business.industry, SARS-CoV-2, RC86-88.9, Research, Medical emergencies. Critical care. Intensive care. First aid, Oxygenation, Middle Aged, medicine.disease, Respiration, Artificial, Respiratory Function Tests, [SDV] Life Sciences [q-bio], Compliance (physiology), Clinical trial, Intensive Care Units, 030228 respiratory system, Anesthesia, Female, Blood Gas Analysis, business, Covid-19, Body mass index
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfb7b97a1c467f4a725a149778e8a4dbTest
https://doaj.org/article/d8865fbee26d49d49969c5f7b910ae47Test -
3
المساهمون: Hôpital de la Croix-Rousse [CHU - HCL], Hospices Civils de Lyon (HCL), Institut de Chimie et Biochimie Moléculaires et Supramoléculaires (ICBMS), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-École Supérieure de Chimie Physique Électronique de Lyon (CPE)-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS), Groupement Hospitalier Nord des HCL [Lyon], RICHARD, Jean-Christophe
المصدر: Critical Care, Vol 24, Iss 1, Pp 1-2 (2020)
Critical Care
Critical Care, 2020, 24 (1), pp.588. ⟨10.1186/s13054-020-03307-5⟩مصطلحات موضوعية: 2019-20 coronavirus outbreak, medicine.medical_specialty, China, Coronavirus disease 2019 (COVID-19), [SDV]Life Sciences [q-bio], Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Critical Illness, Pneumonia, Viral, Critical Care and Intensive Care Medicine, Betacoronavirus, Bronchoscopy, medicine, Research Letter, Humans, Intensive care medicine, Pandemics, ComputingMilieux_MISCELLANEOUS, Retrospective Studies, Invasive Pulmonary Aspergillosis, Critically ill, business.industry, SARS-CoV-2, lcsh:Medical emergencies. Critical care. Intensive care. First aid, COVID-19, Retrospective cohort study, lcsh:RC86-88.9, [SDV] Life Sciences [q-bio], Empirical treatment, Invasive fungal disease, business, Coronavirus Infections
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cd3ed1e13ddfd8b7af2e1602c9d5f01Test
http://link.springer.com/article/10.1186/s13054-020-03307-5Test